336 related articles for article (PubMed ID: 19450958)
1. Alpha-1-antitrypsin deficiency in Madeira (Portugal): the highest prevalence in the world.
Spínola C; Bruges-Armas J; Pereira C; Brehm A; Spínola H
Respir Med; 2009 Oct; 103(10):1498-502. PubMed ID: 19450958
[TBL] [Abstract][Full Text] [Related]
2. Alpha-1-antitrypsin deficiency in the Cape Verde islands (Northwest Africa): High prevalence in a sub-Saharan population.
Spínola C; Brehm A; Spínola H
Respir Med; 2010 Jul; 104(7):1069-72. PubMed ID: 20226649
[TBL] [Abstract][Full Text] [Related]
3. Screening for alpha1-antitrypsin deficiency in Lithuanian patients with COPD.
Sitkauskiene B; Serapinas D; Blanco I; Fernández-Bustillo E; Janciauskiene S; Sakalauskas R
Respir Med; 2008 Nov; 102(11):1654-8. PubMed ID: 18722101
[TBL] [Abstract][Full Text] [Related]
4. Ethnic differences in alpha-1 antitrypsin deficiency in the United States of America.
de Serres FJ; Blanco I; Fernández-Bustillo E
Ther Adv Respir Dis; 2010 Apr; 4(2):63-70. PubMed ID: 20435667
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of PI*S and PI*Z SERPINA1 alleles in healthy individuals and COPD patients in Saudi Arabia: A case-control study.
Al-Jameil N; Hassan AA; Hassanato R; Isac SR; Otaiby MA; Al-Shareef F; Al-Maarik B; Ajeyan IA; Al-Bahloul K; Ghani S; Al-Torbak D
Medicine (Baltimore); 2017 Oct; 96(42):e8320. PubMed ID: 29049242
[TBL] [Abstract][Full Text] [Related]
6. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting.
Bull World Health Organ; 1997; 75(5):397-415. PubMed ID: 9447774
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of alpha(1)-antitrypsin deficiency in a representative population sample from Poland.
Kaczor MP; Sanak M; Libura-Twardowska M; Szczeklik A
Respir Med; 2007 Dec; 101(12):2520-5. PubMed ID: 17693072
[TBL] [Abstract][Full Text] [Related]
8. Population genetic screening for alpha1-antitrypsin deficiency in a high-prevalence area.
Corda L; Medicina D; La Piana GE; Bertella E; Moretti G; Bianchi L; Pinelli V; Savoldi G; Baiardi P; Facchetti F; Gatta N; Annesi-Maesano I; Balbi B
Respiration; 2011; 82(5):418-25. PubMed ID: 21474916
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.
Hollander C; Westin U; Wallmark A; Piitulainen E; Sveger T; Janciauskiene SM
BMC Pulm Med; 2007 Jan; 7():1. PubMed ID: 17261175
[TBL] [Abstract][Full Text] [Related]
10. The protease inhibitor PI*S allele and COPD: a meta-analysis.
Dahl M; Hersh CP; Ly NP; Berkey CS; Silverman EK; Nordestgaard BG
Eur Respir J; 2005 Jul; 26(1):67-76. PubMed ID: 15994391
[TBL] [Abstract][Full Text] [Related]
11. Relation of functional characteristics and serum alpha-1-antitrypsin (AAT) concentration in patients with PiMM phenotype and chronic obstructive pulmonary disease (COPD).
Zarić B; Stojčević J; Andrijević L; Andrijević I; Kuruc V; Veselinović I; Salatić I
Eur J Intern Med; 2011 Dec; 22(6):603-6. PubMed ID: 22075288
[TBL] [Abstract][Full Text] [Related]
12. Serum levels and genotype distribution of α1-antitrypsin in the general population.
Ferrarotti I; Thun GA; Zorzetto M; Ottaviani S; Imboden M; Schindler C; von Eckardstein A; Rohrer L; Rochat T; Russi EW; Probst-Hensch NM; Luisetti M
Thorax; 2012 Aug; 67(8):669-74. PubMed ID: 22426792
[TBL] [Abstract][Full Text] [Related]
13. Alpha-1 Antitrypsin Deficiency in COPD Patients: A Cross-Sectional Study.
Sorroche PB; Fernández Acquier M; López Jove O; Giugno E; Pace S; Livellara B; Legal S; Oyhamburu J; Saez MS
Arch Bronconeumol; 2015 Nov; 51(11):539-43. PubMed ID: 25800328
[TBL] [Abstract][Full Text] [Related]
14. Alpha-1 antitrypsin Null mutations and severity of emphysema.
Fregonese L; Stolk J; Frants RR; Veldhuisen B
Respir Med; 2008 Jun; 102(6):876-84. PubMed ID: 18353624
[TBL] [Abstract][Full Text] [Related]
15. [Study of the frequency of different phenotypes of alpha-1-antitrypsin in a population of Barcelona].
Vidal R; Miravitlles M; Jardí R; Torrella M; Rodríguez-Frías F; Moral P; Vaqué J
Med Clin (Barc); 1996 Jul; 107(6):211-4. PubMed ID: 8755448
[TBL] [Abstract][Full Text] [Related]
16. PCR-based screening for the most prevalent alpha 1 antitrypsin deficiency mutations (PI S, Z, and Mmalton) in COPD patients from Eastern Tunisia.
Denden S; Lakhdar R; Keskes NB; Hamdaoui MH; Chibani JB; Khelil AH
Biochem Genet; 2013 Oct; 51(9-10):677-85. PubMed ID: 23666394
[TBL] [Abstract][Full Text] [Related]
17. Heritability of lung function in severe alpha-1 antitrypsin deficiency.
DeMeo DL; Campbell EJ; Brantly ML; Barker AF; Eden E; McElvaney NG; Rennard SI; Stocks JM; Stoller JK; Strange C; Turino G; Sandhaus RA; Silverman EK
Hum Hered; 2009; 67(1):38-45. PubMed ID: 18931508
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of α-1-antitrypsin gene mutations in Saudi Arabia.
Aljarallah B; Ali A; Dowaidar M; Settin A
Saudi J Gastroenterol; 2011; 17(4):256-60. PubMed ID: 21727732
[TBL] [Abstract][Full Text] [Related]
19. Rapid and inexpensive detection of alpha1-antitrypsin deficiency-related alleles S and Z by a real-time polymerase chain reaction suitable for a large-scale population-based screening.
Kaczor MP; Sanak M; Szczeklik A
J Mol Diagn; 2007 Feb; 9(1):99-104. PubMed ID: 17251342
[TBL] [Abstract][Full Text] [Related]
20. Alpha-antitrypsin genotypes in Korean patients with chronic obstructive pulmonary disease.
Kim CH; Yim JJ; Yoo CG; Lee CT; Kim YW; Han SK; Shim YS
Respirology; 2005 Mar; 10(2):223-8. PubMed ID: 15823189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
